Christian Pfister

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Studies of Asian societyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 13, 2024
Perioperative chemotherapy in bladder cancer: the more cisplatin, the best survival?

Christian Pfister, Valentin Harter, Yves Allory

|Mar 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Stéphane Culine, Valentin Harter, Clémentine Krucker

|Jun 15, 2022
Reply to S. Zeng et al.

Christian Pfister, Valentin Harter, Yves Allory

|Mar 07, 2022
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER Trial.

Christian Pfister, Gwenaelle Gravis, Aude Fléchon

|Sep 06, 2019
Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC).

Clara Delcourt, Pierre Gemival, François Xavier Nouhaud

Pageof 1

Frequent Collaborators

3 joint publications

Yves Allory

3 joint publications

Valentin Harter

2 joint publications

Stéphane Culine

1 joint publications

Gwenaelle Gravis